Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs

Published:2023-02 Issue:1 Volume:8 Page:100749
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Overbeek J.K.,ter Heine R.,Verheul H.M.W.,Chatelut E.,Rudek M.A.,Gurney H.,Plummer R.,Gilbert D.C.,Buclin T.,Burger D.M.,Bloemendal H.J.,van Erp N.P.

Funder

ZonMw

National Cancer Institute

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference56 articles.

1. Dose selection and tolerability of anticancer agents evaluated by the European Medicines Agency in the period 2015-2020;Maliepaard;ESMO Open,2021

2. The drug-dosing conundrum in oncology – when less is more;Shah;N radEngl J Med,2021

3. Interventional pharmacoeconomics: a novel mechanism for unlocking value;Serritella;Clin Pharmacol Ther,2020

4. The effect of using pazopanib with food vs. fasted on pharmacokinetics, patient safety, and preference (DIET Study);Lubberman;Clin Pharmacol Ther,2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose selection of novel anticancer drugs: exposing the gap between selected and required doses;The Lancet Oncology;2024-08

2. Population Pharmacokinetics in Oncology and Its Clinical Applications;Pharmaceutics;2024-05-25

3. Optimising oncology drug expenditure in Ireland;Irish Journal of Medical Science (1971 -);2024-04-03

4. High-dose short-term osimertinib treatment is effective in patient-derived metastatic colorectal cancer organoids;BJC Reports;2024-04-03

5. Integrating treatment cost reduction strategies and biomarker research to reduce costs and personalize expensive treatments: an example of a self-funding trial in non-small cell lung cancer;Frontiers in Pharmacology;2023-11-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3